Измени мозг - изменится и тело - Амен Дэниел Грегори - Страница 85

• Предыдущая
• 85/91
• Следующая

Глава 6

Arcka, P., Pausb, R. 2006. From the brain-skin connection: the neuroendocrine- immune misalliance of stress and itch. Neuroimmunomodulation 13:347–356.

Beitner, H. 2003. Randomized, placebo-controlled, double blind study on the clinical efficacy of a cream containing 5 % alpha-lipoic acid related to photoageing of facial skin. British Journal of Dermatology 149(4):841-9.

Girotti, A.W. 1998. Lipid hydroperoxide generation, turnover, and effector action in biological systems. Journal of Lipid Research 39:1529–1542.

Grossman R. 2005. The role of dimethylaminoethanol in cosmetic dermatology. American Journal of Clinical Dermatology 6(l):39–47.

He, Q.C., Tavakkol, A., Wietecha, K., Begum-Gafur, R., Ansari, S.A., Polefka, T. 2006. Effects of environmentally realistic levels of ozone on stratum corneum function. International Journal of Cosmetic Science 28(5):349-57.

Joachim, R.A. 2007. Neuronal plasticity of the brain-skin connections stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. Journal of Molecular Medicine 85(12): 1369-78.

Lauritzen, C. Studd, J. Current Management of the Menopause. Taylor & Francis Group, 2005.

Model, D. 1985. Smoker’s face: an underrated clinical sign? British Medical Journal (Clinical Researc Ed). 291(6511):1760—2.

Neckelmann, D., Mykletun, A., Dahl, A., 2007. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 30(7):873–880.

Nixon, R. Your skin produces marijuana-like substance, LiveScience, July 11,2008.

Pageon, H., Techer, M.R, Asselineau, D. 2008. Reconstructed skin modified by glycation of the dermal equivalent as a model for skin aging and its potential use to evaluate anti-glycation molecules. Experimental Gerontology 43(6):584-8.

Paus, R., Theoharides, T., Arck, P.C. 2006. Neuroimmunoendocrine circuitry of the brain-skin connection. Trends in Immunology Vol. 27 No. 1.

Persson, M.L., Johansson, J., Vumma, R. Raita, J., Bjerkenstedt, L., Wiesel, EA., Venizelos, N. 2009. Aberrant amino acid transport in fibroblasts from patients with bipolar disorder. Neuroscience Letters 457(1):49–52.

Rabat, M. Rejuvenate your skin while you sleep. Life Extension Magazine August, 2003.

Repinski, K. Face facts: Too much sugar can cause wrinkles. Prevention 10/21/2007.

Sofie, A.E. Hertog, D., Wensveen, C.A.H., Bastiaens, M.T., Kielich, C.J., Berkhout, M.J.P., Westendorp, R.G.J., Vermeer, B.J., Bouwes Bavinck, J.N. 2001. Relation between smoking and skin cancer. Journal of Clinical Oncology 19(1):231–238.

Thom, E. 2005. A randomized, double-blind, placebo-controlled study on the clinical efficacy of oral treatment with DermaVite on ageing symptoms of the skin. Journal of International Medical Research 33(3):267–272.

Van der Leun, J.C., Piacentini R.D., de Gruijl, F.R. 2008. Climate change and human skin cancer. Photochemical & Photobiological Sciences 7(6):730-3.

Wang, Y.J., Thomas, P., Zhong, J.H., Bi, F.F., Kosaraju, S., Pollard, A., Fenech, M., Zhou, X.F. 2009. Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer’s disease mouse. Neurotoxicity Research 15(1):3—14.

Ye, X., Tong, Z. Dang, Y. Tu, Q. Weng, Y. Liu, J., Zhang, Z. 2009. Effects of blood glucose fluctuation on skin biophysical properties, structure and antioxidant status in an animal model. Clinical and Experimental Dermatology July 6. [Epub ahead of print].

Yosipovitch, G., Ishiuji, Y., Patel, T.S., Hicks, M.I., Oshiro, Y. Kraft, R.A., Winnicki, E., Coghill, R.C. 2008. The brain processing of scratching. Journal of Investigative Dermatology Jul;128(7): 1806—11.

Глава 7

Ainslie, P.N., Cotter, J.D., George, K.P, Lucas, S., Murrell, C., Shave, R. Thomas, K.N., Williams, M.J., Atkinson, G. 2008. Elevation in cerebral blood flow velocity with aerobic fitness throughout healthy human aging. Journal of Physiology 586(16):4005-10.

Alumad, A.M., Hopkins, M.T., Weston, P.J., Fraser, W.D., Vora, J.P. 2002. Effects of GH replacement on 24-h ambulatory blood pressure an its circadian rhythm in adult GH deficiency. Clinical Endocrinology (Oxf) 56(4):431-7.

Arnold, S., Beyer, C. 2009. Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. Journal of Neurochemistry May 29. (Epub ahead of print).

Baca-Garcia, E., Diaz-Sastre, C., de Leon, J., Saiz-Ruiz, J. 2000. The relationship between menstrual cycle phases and suicide attempts. Psychosomatic Medicine 62:50–60.

Barron, A.M., Fuller, S.J., Verdile, G., Martins, R.N. 2006. Reproductive hormones modulate oxidative stress in Alzheimer’s disease. Antioxidants 8c Redox Signaling 8(ll-12):2047-59.

Bergemann, N., Parzer, P., Nagl, I., Salbach, B. Mundt, Ch., Resch, F. 2002. Acute psychiatric admission and menstrual cycle phase in women with schizophrenia. Journal Archives of Womens Mental Health 5(3):119–126.

Bialek, M., Zaremba, P., Borowicz, K.K., Czuczwar, S.J. 2004. Neuroprotective role of testosterone in the nervous system. Polish Journal of Pharmacology 56(5):509-18.

Bosevski, M., Tosev, S., Sadikario, S. 2008. Premature atherosclerosis in patients with growth hormone deficiency and diabetes mellitus. Bratisl Lek Listy 109(6):279-80.

Braverman, E.R., Chen, T., Prihoda, T., Sonntag, W., Meshkin, B. Downs, W., Mengucci, J., Blum, S., Notaro, A., Arcuri, V., Varshavskiy, M. Blum, K. 2007. Plasma growth hormones, p300 event-related potential and test of variables of attention (t.o.v.a) are important neuroendocrinological predictors of early cognitive decline in clinical setting: evidence supported by structural equation modeling parameter estimates. Age 29(2–3):55–67.

Bush, A.L., Allen, P.A., Kaut, K.P., Ogrocki, P.K. 2007. Influence of mild cognitive impairment on visual word recognition. Neuropsychoogy, Development, and Cognition Section B Aging, Neuropsychology and Cognition 14(4):329-52.

Colao, A., Di Somma, C., Spiezia, S., Savastano, S., Rota, E, Savanelli, M.C., Lombardi, G. 2008. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency. Journal of Clinical Endocrinology & Metabolism 93(9):3416-24.

Colao, A., Di Somma, C. Cascella, T., Pivonello, R. Vitale, G., Grasso, L.F., Lombardi, G., Savastano, S. 2008. Relationship between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. European Journal of Endocrinology 159(4):389-97.

Doncarlos, L.L., Azcoitia, I., Garcia-Segura, L.M. 2009. Neuroprotective actions of selective estrogen receptor modulators. Psychoneuroendocrinology May 15. [Epub ahead of print].

Elliott, S.S., Keim, N.L., Stern, J.S., Teff, K., Havel, P.J. 2002. Fructose, weight gain, and the insulin resistance syndrome. American Journal of Clinical Nutrition 76(5):911–922.

Gao, Q., et al. 2007. Anorectic estrogen mimics leptin’s effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nature Medicine 13(1):89–94.

Giovannini, S., Marzetti, E., Borst, S.E., Leeuwenburgh, C. 2008. Modulation of GH/IGF-1 axis: Potential strategies to counteract sarcopenia in older adults. Mechanisms of Ageing and Development 129(10):593–601.

Gomez, J.M. 2008. Growth hormone and insulin-like growth factor-I as an endocrine axis in Alzheimer’s disease. Endocrine, Metabolic & Immune Disorders — Drug Targets 8(2): 143-51.

Golgeli, A., Tanriverdi, F. Suer, C., Gokce, C., Ozesmi, C., Bayram, F., Kelestimur, F. 2004. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehans syndrome and effects of GH replacement therapy. European Journal of Endocrinology 150(2):153-9.

• Предыдущая
• 85/91
• Следующая